OpenAlex
PricingAboutJobs
Log inGet started
Work

Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations

HTML PDF

Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Respiratory Medicine
DOI: 10.1016/j.rmed.2008.04.019
Authors: Gary T. Ferguson, Antonio Anzueto, Richard Fei, Amanda Emmett, Katharine Knobil, Christopher Kalberg
Institutions: The University of Texas at San Antonio Health Science Center, GlaxoSmithKline (United States)
Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: COPD exacerbations, salmeterol/fluticasone, salmeterol, inhaled corticosteroids, beta2-adrenergic agonists, combination therapy, pneumonia, oral corticosteroids, exacerbation prevention, maintenance therapy, adverse events, long-term treatment outcomes, COPD severity, hospitalization risk, antibiotic use, FEV1 decline, lung function decline
SDG: Good health and well-being

Open Access status: bronze

Funder: GlaxoSmithKline
OpenAlex ID: W2088797046
FWCI: 18.37
Cites: 33
Cited by: 237
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms